What is the most likely diagnosis for an elderly patient with exertional dyspnea, orthopnea, and signs of heart failure, with echocardiography showing concentric left ventricular hypertrophy and a normal ejection fraction (EF) of 60%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Heart Failure with Preserved Ejection Fraction (HFpEF)

The most likely diagnosis is C: Heart failure with preserved ejection fraction (HFpEF). This elderly patient presents with the classic triad of HF symptoms (exertional dyspnea, orthopnea), preserved systolic function (EF 60%), and concentric LVH—the hallmark structural abnormality seen in HFpEF patients with hypertensive heart disease 1.

Diagnostic Reasoning

Why HFpEF is the Answer

  • The patient meets all diagnostic criteria for HFpEF: symptoms and signs of HF, LVEF ≥50% (patient has 60%), and structural cardiac abnormality (concentric LVH) 1, 2

  • Concentric LVH is the defining structural feature: The vast majority of HFpEF patients have a history of hypertension with evidence of LVH on echocardiography 1. This represents chronic pressure overload leading to increased myocardial stiffness and diastolic dysfunction 1

  • The demographic profile fits perfectly: HFpEF is most prevalent among elderly patients, particularly women, with hypertension as the predominant risk factor 1, 3

  • The clinical presentation is typical: Exertional dyspnea and orthopnea reflect elevated LV filling pressures and pulmonary venous congestion characteristic of HFpEF 1, 3, 4

Why Not Restrictive Cardiomyopathy

  • Restrictive cardiomyopathy is in the differential diagnosis of HF with preserved EF, but it represents a specific subset of infiltrative diseases (amyloidosis, sarcoidosis, hemochromatosis) 1

  • The echocardiographic pattern differs: Restrictive cardiomyopathy typically shows biatrial enlargement, normal or reduced LV wall thickness (unless infiltrative), and a restrictive filling pattern with rapid early filling 2

  • Concentric LVH points away from restriction: The presence of concentric hypertrophy suggests chronic pressure overload (hypertension) rather than infiltrative disease 1, 5

  • Additional testing would be needed: Diagnosis of restrictive cardiomyopathy requires specific evaluation for infiltrative processes (cardiac MRI, endomyocardial biopsy, serum/urine protein electrophoresis) 2

Why Not Constrictive Pericarditis

  • Constrictive pericarditis presents with preserved EF but has distinct features that are absent in this case 1

  • Echocardiographic findings differ fundamentally: Constriction shows pericardial thickening, septal bounce, respiratory variation in mitral inflow velocities, and normal LV wall thickness—not concentric LVH 2

  • The pathophysiology is opposite: Constriction involves external restraint by the pericardium preventing ventricular filling, whereas HFpEF involves intrinsic myocardial stiffness from hypertrophy and fibrosis 1, 4

  • Concentric LVH excludes constriction: The presence of LVH indicates a myocardial process, not pericardial disease 2, 5

Clinical Context and Pathophysiology

The HFpEF Syndrome in Elderly Patients

  • Aging profoundly affects diastolic function: Elderly patients develop decreased elastic properties of the heart and great vessels, increased systolic blood pressure, increased myocardial stiffness, and slowed ventricular filling due to fibrosis and impaired relaxation 1

  • Hypertension drives concentric remodeling: Chronic pressure overload leads to concentric LVH as an adaptive response, but this eventually causes diastolic dysfunction with elevated filling pressures 1, 5

  • The morbidity is substantial: HFpEF patients experience frequent hospitalizations and mortality rates nearly as high as HFrEF, with annual mortality approximately 15% 1, 3

Completing the Diagnostic Workup

To confirm HFpEF diagnosis, the following should be obtained:

  • Natriuretic peptide levels: BNP >35 pg/mL or NT-proBNP >125 pg/mL in ambulatory patients supports the diagnosis 1

  • Echocardiographic diastolic parameters: E/e' ratio ≥15 confirms elevated LV filling pressures; E/e' 9-14 is intermediate and may require exercise testing 1, 2

  • Left atrial enlargement: Increased left atrial volume index supports chronically elevated filling pressures 1, 5

  • Exclude HFpEF mimics: Rule out significant valvular disease (especially aortic stenosis, mitral regurgitation), infiltrative cardiomyopathies, and pericardial disease 1, 2

Critical Pitfalls to Avoid

  • Do not assume all dyspnea with preserved EF is HFpEF: Carefully exclude noncardiac causes (pulmonary disease, obesity, deconditioning, anemia) and cardiac mimics (valvular disease, infiltrative disease, constriction) 1, 2

  • Recognize that diastolic dysfunction parameters can be misleading: Loading conditions, heart rate, mitral regurgitation, and age affect Doppler measurements 1

  • Consider exercise testing if resting evaluation is inconclusive: Approximately 35% of HFpEF patients have normal resting hemodynamics but develop elevated filling pressures with exertion 3, 6

  • Do not overlook obesity as a confounder: Obese patients may have lower natriuretic peptide levels despite true HFpEF 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Heart Failure with Preserved Ejection Fraction (HFpEF)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Heart Failure with Preserved Ejection Fraction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.